The transesophageal echocardiography (TEE) market is on a steep growth trajectory, with analysts projecting it to reach $12.5 billion by 2030, expanding at a 9.2% CAGR from 2024. This growth is fueled by a confluence of factors: rising prevalence of cardiovascular diseases (CVDs), advancements in TEE technology, and increasing clinical adoption across hospitals and specialty clinics. TEE, a...